Polynucleotides HPT
Polynucleotides form the characteristic PN component of the formulation.
Newest One combines hyaluronic acid and polynucleotides in a sterile gel for professional use. A strong option when your protocols focus on skin quality and a fresher-looking appearance, especially on body areas that tend to look dry, uneven or “tired.” The texture integrates well into series concepts and combination treatments, and the vial format supports clean, predictable application in practice.
Contents: 5 x 4 ml
Polynucleotides HPT + hyaluronic acid · Mastelli
Newest One by Mastelli is a sterile formulation with Polynucleotides HPT, hyaluronic acid and mannitol. The medical device is designed for professional intradermal applications and its five 4 ml vials provide a practical format for larger body areas.
per vial · per ml incl. VATMedical device. Use only in accordance with the current IFU.
Polynucleotides form the characteristic PN component of the formulation.
Body areas
Newest One is offered for body-focused aesthetic concepts. Use the controls to highlight typical areas in the schematic view.
The treating professional determines the actual area, technique and product amount according to the intended purpose and IFU.
Formula
The Mastelli formula combines Polynucleotides HPT, hyaluronic acid and mannitol in one product.
Polynucleotides form the characteristic PN component of the formulation.
Present as Sodium Hyaluronate, giving the formulation a clear hydration focus.
Mannitol complements the combination of polynucleotides and hyaluronic acid.
Ingredients: Aqua, Polynucleotides, Sodium Hyaluronate, Mannitol, Sodium Phosphate, Disodium Phosphate.
Practice format
The vial size distinguishes Newest One from many prefilled 1–2 ml systems and supports planning for larger areas.
Before use
Overview
Questions
A CE-marked Mastelli medical device with Polynucleotides HPT, hyaluronic acid and mannitol for professional intradermal applications.
Five sterile 4 ml vials, 20 ml in total.
Typical body-focused areas include arms, abdomen, décolleté, buttocks and thighs. The actual choice follows the intended purpose, IFU and medical judgement.
Only appropriately authorised healthcare professionals permitted under national law.
Yes. The formula contains Sodium Hyaluronate together with polynucleotides and mannitol.
In the current instructions for use (IFU), which must be read and followed in full before use.
For healthcare professionals: Medical device for professional intradermal use. Intended purpose and current IFU are binding.
Responsible economic operator according to GPSR:
Mastelli S.r.l.
Via Bussana Vecchia, 32
18038 Sanremo (IM)
Italy
+39 0184 511 522
Product Safety – Summary (based on manufacturer information / MDR)
Product name: Plinest Eye
Manufacturer: Mastelli S.r.l., Via Bussana Vecchia 32, 18038 Sanremo (IM), Italy
CE marking: CE 0373
Product classification: Medical device
Intended use: Intradermal administration in the periocular area by authorised healthcare professionals
Contents: 1× 2 ml sterile prefilled syringe + two 30G ½ needles (Becton Dickinson, CE 0318)
Sterilisation method: EO
CH and UK representatives: As indicated on the product label (e.g., Emergo Consulting UK)
Save products on your wishlist to buy them later or share with your friends.